Cancer therapy developer Orca Bio hopes to turn fresh results from a late-stage clinical trial into regulatory approval next ...
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...
An eight-year-old girl in the U.K. found a life-saving bone marrow donor from across the world just in time for a critical ...
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density neutrophil subsets in myelodysplastic syndromes (MDS), acute myeloid leukemia ...
UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...
Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...
Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...
Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome ...
There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers.
Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...
YOUNGSTOWN, Ohio (MyValleyTributes) – Robert Wayne Compton, 73, passed away Thursday March 6, 2025 at St. Elizabeth Hospital ...